Equities
Health CarePharmaceuticals and Biotechnology
  • Price (CHF)73.15
  • Today's Change-0.40 / -0.54%
  • Shares traded133.94k
  • 1 Year change-20.40%
  • Beta1.0385
Data delayed at least 15 minutes, as of May 16 2022 16:30 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • BANB:SWX price reached a new 52-week low of 67.40 at 10:31 BST
  • BANB:SWX price moved over -1.86% to 68.50

Key statistics

On Monday, Bachem Holding AG (BANB:SWX) closed at 73.15, 9.18% above its 52-week low of 67.00, set on May 12, 2022.
52-week range
Today
67.00May 12 2022171.00Oct 18 2021
Markit short selling activity
Low
Med
High
Open73.80
High73.95
Low70.95
Bid--
Offer73.95
Previous close73.55
Average volume91.46k
Shares outstanding73.75m
Free float62.63m
P/E (TTM)43.15
Market cap5.15bn CHF
EPS (TTM)1.62
CHF
Annual div (ADY)0.70
CHF
Annual div yield (ADY)0.95%
Div ex-dateApr 29 2022
Div pay-dateMay 03 2022
Data delayed at least 15 minutes, as of May 16 2022 16:30 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.